AW

Acqua Wellington Asset Management

North America, New York, United States, New York

Description

Acqua Wellington Asset Management is a New York-based principal investment firm that funds the public equity markets across the globe.

Investor Profile

Acqua Wellington Asset Management has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Acqua Wellington Asset Management frequently co-invest with?

Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
HBK Capital Management
North America, Texas, United States, Dallas
Co-Investments: 1
MB
North America, New York, United States, New York
Co-Investments: 1
Clarion Capital Partners
North America, New York, United States, New York
Co-Investments: 1
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
FM
North America, California, United States, San Francisco
Co-Investments: 1
LG
North America, New York, United States, New York
Co-Investments: 1
AI
North America, New York, United States, Greenport
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
Bank of America Securities
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Acqua Wellington Asset Management?

EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownNov 7, 2006
Amount Raised: $18,600,000